HomeCompareSICPQ vs MRK

SICPQ vs MRK: Dividend Comparison 2026

SICPQ yields 1290.32% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SICPQ wins by $179862397.72M in total portfolio value
10 years
SICPQ
SICPQ
● Live price
1290.32%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$179862397.77M
Annual income
$156,069,016,072,097.00
Full SICPQ calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SICPQ vs MRK

📍 SICPQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSICPQMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SICPQ + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SICPQ pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SICPQ
Annual income on $10K today (after 15% tax)
$109,677.42/yr
After 10yr DRIP, annual income (after tax)
$132,658,663,661,282.45/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SICPQ beats the other by $132,658,663,652,954.05/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SICPQ + MRK for your $10,000?

SICPQ: 50%MRK: 50%
100% MRK50/50100% SICPQ
Portfolio after 10yr
$89931198.92M
Annual income
$78,034,508,040,947.56/yr
Blended yield
86.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SICPQ
Analyst Ratings
8
Buy
9
Hold
5
Sell
Consensus: Hold
Altman Z
-0.5
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SICPQ buys
0
MRK buys
0
No recent congressional trades found for SICPQ or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSICPQMRK
Forward yield1290.32%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$179862397.77M$56.8K
Annual income after 10y$156,069,016,072,097.00$9,798.13
Total dividends collected$178102191.57M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: SICPQ vs MRK ($10,000, DRIP)

YearSICPQ PortfolioSICPQ Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$139,732$129,032.26$11,206$366.19+$128.5KSICPQ
2$1,834,557$1,685,043.81$12,650$502.35+$1.82MSICPQ
3$22,638,762$20,675,786.05$14,407$694.19+$22.62MSICPQ
4$262,674,749$238,451,273.26$16,585$967.82+$262.66MSICPQ
5$2,866,782,089$2,585,720,107.80$19,342$1,363.89+$2866.76MSICPQ
6$29,441,340,826$26,373,883,990.04$22,913$1,947.19+$29441.32MSICPQ
7$284,637,828,462$253,135,593,778.43$27,662$2,823.89+$284637.80MSICPQ
8$2,591,764,208,133$2,287,201,731,679.32$34,159$4,173.35+$2591764.17MSICPQ
9$22,236,805,328,760$19,463,617,626,057.21$43,337$6,308.80+$22236805.29MSICPQ
10$179,862,397,773,870$156,069,016,072,097.00$56,776$9,798.13+$179862397.72MSICPQ

SICPQ vs MRK: Complete Analysis 2026

SICPQStock

Silvergate Capital Corporation operates as a bank holding company for Silvergate Bank that provides banking products and services to business and individual clients in the United States. The company accepts deposit products, including interest and noninterest bearing demand accounts, money market and savings accounts, and certificates of deposit accounts. Its loan products comprise one-to-four family real estate loans, multi-family real estate loans, commercial real estate loans, construction loans, commercial and industrial loans, mortgage warehouse loans, and reverse mortgage loans, as well as consumer loans and other loans secured by personal property. The company also provides cash management services for digital currency-related businesses. Silvergate Capital Corporation was founded in 1988 and is headquartered in La Jolla, California. On September 17, 2024, Silvergate Capital Corporation, along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Full SICPQ Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SICPQ vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SICPQ vs SCHDSICPQ vs JEPISICPQ vs OSICPQ vs KOSICPQ vs MAINSICPQ vs JNJSICPQ vs ABBVSICPQ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.